Getinge announces its continuous commitment to the 38th International Symposium on Intensive Care and Emergency Medicine (ISICEM)
6 March 2018
Brussels, Belgium
Getinge, a leading global provider of innovative medical technology, announces today its continuous commitment to ISICEM. Getinge will sponsor two important scientific sessions on March 21 and 22 where key opinion leaders will present on the ‘Management of the Failing Lung – Concepts and Evidence’ and ‘Heart-lung Interaction and Fluid Management – Pushing boundaries’.
It is anticipated that over 6,000 physicians, nurses and healthcare professionals with a focus on critical care or emergency medicine, from over 100 countries worldwide will attend this international meeting.
“As a major sponsor, this important event enables Getinge to present the full portfolio of intensive care unit (ICU) related products such as Servo-u, Servo-air, Servo-n ventilation systems coupled with a Sokinox device from Air Liquide. For the first time participants will have the opportunity to see the new Getinge Servo-u MR. This symposium also provides attendees with the most recent, clinically relevant developments in research, therapy and management of the critically ill.” shared Markus Stirner-Schilling, Senior Director, Acute Care Therapies, Global Commercial Operations.
About Getinge at ISICEM:
Registered visitors are invited to visit Getinge on Booth: 2.20, 2.21, 2.32 - 2.35, Hall 2 from March 20th – 23rd at Square, Brussels Meeting Centre, Brussels, Belgium.
For further information, please contact
Tracey Dawe
Director Communications - Global Sales
Phone: + 44 77 177 84965 Email: tracey.dawe@getinge.com
About Getinge
Getinge is a global provider of innovative solutions for operating rooms, intensive-care units, sterilization departments and for life science companies and institutions. Based on our first-hand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving every-day life for people, today and tomorrow.
Tags: